Health Health วันนี้ Health ล่าสุด | Page 28 of 133

Krungsri supports Breast Foundation in screening breast cancer for disadvantaged women for 14th year

Mr. Poonsit Wongthawatchai (left), Krungsri Executive Vice President, Head of Environmental, Social and Governance Division, represented Bank of Ayudhya Public Company Limited in presenting a…

Health 17 พ.ย. 66 8:59

thaipr.net

17 พ.ย. 66

Over 86 percent of Thai and Indonesian Women Consider Thalassemia Screening after Learning about Associated Health Risks

Thai (91.2%) and Indonesian (86.6%) women consider screening after learning about health risks and costs which is higher than the global average of 84.5% According to Thailand’s Ministry of…

Health 17 พ.ย. 66 8:002023-11-17

thaipr.net

17 พ.ย. 66

Daewoong Pharmaceutical Announces Successful ‘Extra Strength’ Results of US Phase 2 Clinical Trial for High-dose Administration of Botulinum Toxin

Daewoong Pharmaceutical is proud to announce the successful completion of a Phase 2 clinical trial for its botulinum toxin type-A product in the United States. Evolus announced the long-term effects…

Health 16 พ.ย. 66 8:33

thaipr.net

16 พ.ย. 66

The PolG Foundation awards over $3.5M in academic grants to pioneer POLG research

The PolG Foundation is a nascent foundation established in 2022 by a PolG family, with the mission to support and accelerate research to find effective treatments and a cure for PolG mitochondrial disorders. To view the Multimedia News Release, please click: https://www.multivu.com/players/English/9224051-polg-foundation-awards-academic-grants-pioneer-polg-research/ With both a dedicated and experienced Board of Directors and Scientific…

Health 16 พ.ย. 66 8:30

thaipr.net

16 พ.ย. 66

The Thailanders donates funds to support Chulalongkorn Medical School Foundation

Amorn Sirisiri, Editor in Chief of The Thailanders, donated 100,000 Baht collected from The Thailanders Best Medical Skin and Wellness 2023 for a charity event to Assoc. Prof. Chanchai Sittipunt, …

Health 15 พ.ย. 66 22:48

thaipr.net

15 พ.ย. 66

“Read Medicine Labels” – How to Safely Use Green Chiretta Against COVID-19

Chula Pharmaceutical Science points out the benefits and cautious use of green chiretta to better understand the drug, urging consumers to pay attention to “medicine labels” to choose and use green…

Health 15 พ.ย. 66 14:59

thaipr.net

15 พ.ย. 66

More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds

Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. Seven in ten people living with diabetes (72%) only found out they had diabetes after […]

Health 15 พ.ย. 66 8:25

thaipr.net

15 พ.ย. 66

Always on Alert for Balance Loss with “The Balance Assessment Device,” An Outstanding Innovation by Chula Researcher

Chula Engineering lecturer’s innovation “The Balance Assessment Device”—gold medal winner at ITEX 2023, Malaysia, and recipient of World Invention Intellectual Property Associations’ (WIIPA) Special…

Health 14 พ.ย. 66 11:262023-11-14

thaipr.net

14 พ.ย. 66

Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries

Program aims to address key barriers to genomic sequencing in-country Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs). The program, developed with guidance from […]

Health 14 พ.ย. 66 8:14

thaipr.net

14 พ.ย. 66

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and SciClone Pharmaceuticals (Holdings) Ltd. (“SciClone”), an international biopharmaceutical company, today announced that they have entered into an exclusive sub-licensing agreement to develop and commercialize ORSERDU® (elacestrant) in the People’s Republic of China (China), in an effort to expand treatment options…

Health 9 พ.ย. 66 8:08

thaipr.net

9 พ.ย. 66